Voting participation: approximately 57.8% of total outstanding shares.
Shareholder proposal to amend Article 36 (delete cumulative voting exclusion) rejected: 14.9% of total shares (25.8% of votes cast) in favor.
Management proposals to amend Article 33 (strengthen removal requirements) and Article 49 (fix auditor count at 1) passed with 41.0% and 42.9% of total shares, respectively.
Shareholder proposal to elect non-executive director Kwon Ho-beom rejected: 14.8% support.
Management-backed candidates: inside directors Kim Jeong-hwan and Im Yong-gyu, outside directors Kim Gyu-hee and Yoon Su-bin all elected with ~42.9% support.
New directors' backgrounds: Kim Jeong-hwan (Samsung Medical Device), Im Yong-gyu (Ray quality head), Kim Gyu-hee (Samil PwC, JPMorgan), Yoon Su-bin (Hyundai Canvas, Optimist Korea CEO).
Stock outlook and investment risk: EGM result ensures management stability; limited short-term volatility.
[AI Comprehensive Analysis]The EGM outcome reinforces the current management's control, as all management proposals passed while shareholder activist proposals were defeated. While short-term uncertainty is reduced, the rejection of minority rights initiatives may pose governance risks in the long run.
KOSDAQ Filing Information
Filing: Result of Extraordinary General Meeting of Shareholders